Published on
July 29, 2026
- 13:18 GMT
Scottsdale Research Institute Announces Submission of Investigational New Drug (IND) Application to FDA for Ibogaine HCl
PHOENIX, AZ, UNITED STATES, July 29, 2026 /EINPresswire.com/ -- Ibogaine HCl is an investigational neuroplastogen designed to promote neuroplasticity and restore neural function disrupted by psychological trauma, traumatic brain injury, and substance use …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
